Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying CVS Health Corp (CVS)

Page 1 of 2

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make a proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George Soros hold the necessary resources and abilities to conduct an extensive stock analysis on small-cap stocks, which enable them to make millions of dollars by identifying potential winners within the small-cap galaxy of stocks. This represents the main reason why Insider Monkey takes notice of the hedge fund activity in these overlooked stocks.

CVS Health Corp (NYSE:CVS) shareholders have witnessed an increase in the hedge fund interest of late. At the end of this article, we will also compare CVS Health Corp (NYSE:CVS) to other stocks, including Allergan, PLC. (NYSE:AGN), Altria Group Inc (NYSE:MO), and Amgen, Inc. (NASDAQ:AMGN) to get a better sense of its popularity.

Follow Cvs Health Corp (NYSE:CVS)
Trade (NYSE:CVS) Now!

At the moment there are tons of gauges stock traders put to use to size up their stock investments. Two of the less known gauges are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the best picks of the best hedge fund managers can beat their index-focused peers by a superb margin (see the details here).

Keeping this in mind, we’re going to view the key action regarding CVS Health Corp (NYSE:CVS).

What does the smart money think about CVS Health Corp (NYSE:CVS)?

At the end of the third quarter, a total of 60 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 5% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were increasing their stakes significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, AQR Capital Management, managed by Cliff Asness, holds the largest position in CVS Health Corp (NYSE:CVS). AQR Capital Management has a $388.9 million position in the stock, comprising 0.8% of its 13F portfolio. On AQR Capital Management’s heels is Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, which holds a $208.2 million position; the fund has 1% of its 13F portfolio invested in the stock. Other peers that are bullish comprise Phill Gross and Robert Atchinson’s Adage Capital Management, Israel Englander’s Millennium Management, and Charles de Vaulx’s International Value Advisers.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!